Akash Nanda

1.9k total citations
24 papers, 1.5k citations indexed

About

Akash Nanda is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Radiation. According to data from OpenAlex, Akash Nanda has authored 24 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 6 papers in Molecular Biology and 6 papers in Radiation. Recurrent topics in Akash Nanda's work include Prostate Cancer Diagnosis and Treatment (12 papers), Prostate Cancer Treatment and Research (12 papers) and Advanced Radiotherapy Techniques (6 papers). Akash Nanda is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (12 papers), Prostate Cancer Treatment and Research (12 papers) and Advanced Radiotherapy Techniques (6 papers). Akash Nanda collaborates with scholars based in United States, Japan and India. Akash Nanda's co-authors include Brad St. Croix, Bert Vogelstein, Kenneth W. Kinzler, Eleanor B. Carson-Walter, D. Neil Watkins, Sujay Singh, Ming‐Hui Chen, Steven Seaman, Susan Cooley and Brian D. Kavanagh and has published in prestigious journals such as Proceedings of the National Academy of Sciences, JAMA and Journal of Biological Chemistry.

In The Last Decade

Akash Nanda

21 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Akash Nanda United States	14	651	624	275	269	216	24	1.5k
Julian D. Down United States	23	471 0.7×	532 0.9×	295 1.1×	145 0.5×	314 1.5×	50	2.0k
Shinya Neri Japan	19	525 0.8×	562 0.9×	1.1k 3.8×	119 0.4×	366 1.7×	36	1.7k
Wolf‐Dietrich Beecken Germany	15	268 0.4×	356 0.6×	426 1.5×	40 0.1×	164 0.8×	24	1.1k
Mari Tokita United States	13	254 0.4×	304 0.5×	99 0.4×	256 1.0×	251 1.2×	23	972
Kerstin Borgmann Germany	32	497 0.8×	1.8k 2.8×	1.2k 4.3×	99 0.4×	712 3.3×	85	2.7k
Iris Eke Germany	27	374 0.6×	1.0k 1.6×	886 3.2×	63 0.2×	460 2.1×	52	2.1k
Jarmo Kulmala Finland	18	320 0.5×	343 0.5×	339 1.2×	123 0.5×	143 0.7×	51	1.0k
Pierre-Yves Dietrich Switzerland	13	536 0.8×	942 1.5×	624 2.3×	26 0.1×	569 2.6×	14	2.5k
Anna Wilkins United Kingdom	16	400 0.6×	340 0.5×	640 2.3×	98 0.4×	140 0.6×	39	1.3k
David Clouston Australia	20	557 0.9×	453 0.7×	279 1.0×	53 0.2×	202 0.9×	49	1.3k

Countries citing papers authored by Akash Nanda

Since Specialization

Citations

This map shows the geographic impact of Akash Nanda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akash Nanda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akash Nanda more than expected).

Fields of papers citing papers by Akash Nanda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akash Nanda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akash Nanda. The network helps show where Akash Nanda may publish in the future.

Co-authorship network of co-authors of Akash Nanda

This figure shows the co-authorship network connecting the top 25 collaborators of Akash Nanda. A scholar is included among the top collaborators of Akash Nanda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akash Nanda. Akash Nanda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Henderson, Randal H., R.C. Nichols, William M. Mendenhall, et al.. (2021). Consensus Statement on Proton Therapy for Prostate Cancer. International Journal of Particle Therapy. 8(2). 1–16. 18 indexed citations

Hannan, Raquibul, Vasu Tumati, Xian‐Jin Xie, et al.. (2016). Stereotactic body radiation therapy for low and intermediate risk prostate cancer—Results from a multi-institutional clinical trial. European Journal of Cancer. 59. 142–151. 116 indexed citations

Braunstein, Lior Z., Ming‐Hui Chen, Daniel E. Dosoretz, et al.. (2015). Whole Pelvis Versus Prostate-Only Radiotherapy With or Without Short-Course Androgen Deprivation Therapy and Mortality Risk. Clinical Genitourinary Cancer. 13(6). 555–561. 4 indexed citations

Cho, L. Chinsoo, Christopher Straka, Alana Christie, et al.. (2014). Predictors of Rectal Tolerance Observed in a Dose-Escalated Phase 1-2 Trial of Stereotactic Body Radiation Therapy for Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 89(3). 509–517. 151 indexed citations

Nanda, Akash, Ming‐Hui Chen, Brian J. Moran, Michelle H. Braccioforte, & Anthony V. D’Amico. (2013). Cardiovascular Comorbidity and Mortality in Men With Prostate Cancer Treated With Brachytherapy-Based Radiation With or Without Hormonal Therapy. International Journal of Radiation Oncology*Biology*Physics. 85(5). e209–e215. 6 indexed citations

Straka, Christopher, Xianjin Xie, Yair Lotan, et al.. (2013). Predictors of High-Grade Rectal Toxicity Observed in a Phase 1/2 Trial of Stereotactic Body Radiation Therapy for Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 87(2). S358–S359. 1 indexed citations

Nanda, Akash, Ming‐Hui Chen, Brian J. Moran, et al.. (2012). Neoadjuvant Hormonal Therapy Use and the Risk of Death in Men with Prostate Cancer Treated with Brachytherapy Who Have No or at Least a Single Risk Factor for Coronary Artery Disease. European Urology. 65(1). 177–185. 22 indexed citations

Wang, Meng, David M. Sander, Liliana Gheorghiu, et al.. (2011). EGF Receptor Inhibition Radiosensitizes NSCLC Cells by Inducing Senescence in Cells Sustaining DNA Double-Strand Breaks. Cancer Research. 71(19). 6261–6269. 96 indexed citations

Nanda, Akash. (2010). Hormonal Therapy for Prostate Cancer in Men With Heart Disease—Reply. JAMA. 303(1). 32–32.

10.

Nanda, Akash. (2009). Hormonal Therapy Use for Prostate Cancer and Mortality in Men With Coronary Artery Disease–Induced Congestive Heart Failure or Myocardial Infarction. JAMA. 302(8). 866–866. 208 indexed citations

11.

Nanda, Akash, Ming‐Hui Chen, Brian J. Moran, et al.. (2009). Predictors of Prostate Cancer–Specific Mortality in Elderly Men With Intermediate-Risk Prostate Cancer Treated With Brachytherapy With or Without External Beam Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 77(1). 147–152. 11 indexed citations

12.

Nanda, Akash, Ming‐Hui Chen, Andrew A. Renshaw, & Anthony V. D’Amico. (2009). Gleason Pattern 5 Prostate Cancer: Further Stratification of Patients With High-Risk Disease and Implications for Future Randomized Trials. International Journal of Radiation Oncology*Biology*Physics. 74(5). 1419–1423. 58 indexed citations

13.

Nanda, Akash, Ming‐Hui Chen, Brian J. Moran, et al.. (2009). Total Androgen Blockade Versus a Luteinizing Hormone–Releasing Hormone Agonist Alone in Men With High-Risk Prostate Cancer Treated With Radiotherapy. International Journal of Radiation Oncology*Biology*Physics. 76(5). 1439–1444. 9 indexed citations

14.

Nanda, Akash, et al.. (2009). Cardiac Comorbidity and Mortality in Men with Prostate Cancer Treated with Brachytherapy with or without Neoadjuvant Hormonal Therapy. International Journal of Radiation Oncology*Biology*Physics. 75(3). S88–S88.

15.

Nanda, Akash, Dora Dias‐Santagata, Hannah Stubbs, et al.. (2008). Unusual Tumor Response and Toxicity from Radiation and Concurrent Erlotinib for Non–Small-Cell Lung Cancer. Clinical Lung Cancer. 9(5). 285–287. 21 indexed citations

16.

Nanda, Akash & Anthony V. D’Amico. (2008). Combined radiation and hormonal therapy or dose escalation for men with unfavourable‐risk prostate cancer: an evidence‐based approach using a synthesis of randomized clinical trials. British Journal of Urology. 102(10). 1366–1368. 2 indexed citations

17.

Nanda, Akash, Baktiar Karim, Zhongsheng Peng, et al.. (2006). Tumor endothelial marker 1 ( Tem1 ) functions in the growth and progression of abdominal tumors. Proceedings of the National Academy of Sciences. 103(9). 3351–3356. 122 indexed citations

18.

Nanda, Akash, Eleanor B. Carson-Walter, Steven Seaman, et al.. (2004). TEM8 Interacts with the Cleaved C5 Domain of Collagen α3(VI). Cancer Research. 64(3). 817–820. 158 indexed citations

19.

Nanda, Akash & Brad St. Croix. (2003). Tumor endothelial markers: new targets for cancer therapy. Current Opinion in Oncology. 16(1). 44–49. 110 indexed citations

20.

Nishikawa, Atsushi, Akash Nanda, Walter Gregory, John Frenz, & Stuart Kornfeld. (1999). Identification of Amino Acids That Modulate Mannose Phosphorylation of Mouse DNase I, a Secretory Glycoprotein. Journal of Biological Chemistry. 274(27). 19309–19315. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact